Illumina Inc (ILMN US)

Analysis

Health Care • United States

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Refresh

Exchange Announcement • 14 Oct 2026 04:48

Current Report (Form 8-K | Period ending 2026-10-13)

Exchange Announcement • 18 Aug 2026 04:02

Current Report (Form 8-K | Period ending 2026-08-17)

Exchange Announcement • 14 Aug 2026 04:18

Current Report (Form 8-K | Period ending 2026-08-13)

Exchange Announcement • 13 Aug 2026 04:22

424B2 | Prospectus

Exchange Announcement • 12 Aug 2026 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Current Report (Form 8-K | Period ending 2026-10-13)

Current Report (Form 8-K | Period ending 2026-08-17)

Current Report (Form 8-K | Period ending 2026-08-13)

424B2 | Prospectus

Current Report (Form 8-K | Period ending 2026-08-10)